BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...
Genetic variations may help explain why patients respond differently to popular weight-loss drugs, according to a new study.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する